These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39313164)

  • 1. Multispectral and molecular simulation of the interaction of human α1-acid glycoprotein with palbociclib.
    Jiang SL; Wu YT; Chen WC; Huang JP; Chen D; Li L; Han L; Shi JH
    Biochim Biophys Acta Gen Subj; 2024 Nov; 1868(11):130712. PubMed ID: 39313164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights on the interaction mechanism of brigatinib to human α-1-acid glycoprotein: Experimental and computational approaches.
    Wang BL; Kou SB; Lin ZY; Shi JH; Liu YX
    Int J Biol Macromol; 2020 Aug; 157():340-349. PubMed ID: 32335105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation on the binding behavior of human α1-acid glycoprotein with Janus Kinase inhibitor baricitinib: Multi-spectroscopic and molecular simulation methodologies.
    Jiang SL; Hu ZY; Wang WJ; Hu L; Li L; Kou SB; Shi JH
    Int J Biol Macromol; 2023 Jul; 244():125096. PubMed ID: 37285878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight into intermolecular binding mechanism of apatinib mesylate and human alpha-1-acid glycoprotein: combined multi-spectroscopic approaches with
    Jiang SL; Li L; Kou SB; Hu L; Shi JH
    J Biomol Struct Dyn; 2024; 42(2):779-790. PubMed ID: 37000929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro investigation of the binding characteristics of dacomitinib to human α 1-acid glycoprotein: Multispectral and computational modeling.
    Hu ZY; Sui HY; Zhong QF; Hu L; Shi JH; Jiang SL; Han L
    Spectrochim Acta A Mol Biomol Spectrosc; 2024 Jun; 314():124197. PubMed ID: 38554689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the binding behavior of ceritinib on human α-1 acid glycoprotein: Multi-spectroscopic and molecular modeling approaches.
    Wang BL; Kou SB; Lin ZY; Shi JH
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 May; 232():118160. PubMed ID: 32113179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehending binding features between ibrutinib and Human Alpha-1 acid glycoprotein: Combined experimental approaches and theoretical simulations.
    Jiang SL; Li L; Hu L; Kou SB; Shi JH
    Spectrochim Acta A Mol Biomol Spectrosc; 2023 Jan; 285():121834. PubMed ID: 36116409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidation of the interaction mechanism of olmutinib with human α-1 acid glycoprotein: insights from spectroscopic and molecular modeling studies.
    Kou SB; Li L; Zhang RJ; Shi JH; Jiang SL
    J Biomol Struct Dyn; 2023 Feb; 41(2):525-537. PubMed ID: 34844510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical insights into the interaction of clofazimine with human alpha 1-acid glycoprotein: a multitechnique approach.
    Ajmal MR; Almutairi F; Zaidi N; Alam P; Siddiqi MK; Khan MV; Zaman M; Ishtikhar M; Khan RH
    J Biomol Struct Dyn; 2019 Apr; 37(6):1390-1401. PubMed ID: 29669491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehending the intermolecular interaction of JAK inhibitor fedratinib with bovine serum albumin (BSA)/human alpha-1-acid glycoprotein (HAG): Multispectral methodologies and molecular simulation.
    Jiang SL; Wang WJ; Hu ZY; Zhang RJ; Shi JH
    Spectrochim Acta A Mol Biomol Spectrosc; 2024 Jan; 304():123277. PubMed ID: 37625199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the binding characteristics between lorlatinib and human alpha-1-acid glycoprotein: Multispectral and molecular modeling techniques.
    Sui HY; Chen D; Huang JP; Hu ZY; Hu L; Shi JH; Jiang SL
    Spectrochim Acta A Mol Biomol Spectrosc; 2025 Feb; 326():125197. PubMed ID: 39368180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Binding Analysis of N-Acetylneuraminic Acid in Bovine Serum Albumin and Human α-1 Acid Glycoprotein.
    Karthikeyan S; Bharanidharan G; Ragavan S; Kandasamy S; Chinnathambi S; Udayakumar K; Mangaiyarkarasi R; Sundaramoorthy A; Aruna P; Ganesan S
    J Chem Inf Model; 2019 Jan; 59(1):326-338. PubMed ID: 30481010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the interaction between α-1-acid glycoprotein (AGP) and potential Cu/Zn metallo-drugs of benzimidazole derived organic motifs: A multi-spectroscopic and molecular docking study.
    AlAjmi MF; Rehman MT; Khan RA; Khan MA; Muteeb G; Khan MS; Noman OM; Alsalme A; Hussain A
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Jan; 225():117457. PubMed ID: 31450223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palbociclib can overcome mutations in cyclin dependent kinase 6 that break hydrogen bonds between the drug and the protein.
    Hernandez Maganhi S; Jensen P; Caracelli I; Zukerman Schpector J; Fröhling S; Friedman R
    Protein Sci; 2017 Apr; 26(4):870-879. PubMed ID: 28168755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-spectroscopic, thermodynamic, and molecular docking/dynamic approaches for characterization of the binding interaction between calf thymus DNA and palbociclib.
    Magdy G; Shaldam MA; Belal F; Elmansi H
    Sci Rep; 2022 Aug; 12(1):14723. PubMed ID: 36042232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity and comparative binding mechanism of piperine with human serum albumin and α-1-acid glycoprotein.
    Yeggoni DP; Rachamallu A; Kallubai M; Subramanyam R
    J Biomol Struct Dyn; 2015; 33(6):1336-51. PubMed ID: 25054206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential interactions and structural stability of chitosan oligomers with human serum albumin and α-1-glycoprotein.
    Gokara M; Kimavath GB; Podile AR; Subramanyam R
    J Biomol Struct Dyn; 2015; 33(1):196-210. PubMed ID: 24359035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palbociclib (PD 0332991) Interaction with Kinases. Theoretical and Comparative Molecular Docking Study.
    Aceves-Hernández JM; Inés Nicolás Vázquez M; Luis Garza Rivera J; Espinoza Godínez A; Mateo Flores J; de Jesús Cruz Guzmán J; Castaño VM
    Chem Biodivers; 2023 Mar; 20(3):e202200554. PubMed ID: 36799136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of new kinase inhibitors cabozantinib and tofacitinib with human serum alpha-1 acid glycoprotein. A comprehensive spectroscopic and molecular Docking approach.
    Ajmal MR; Abdelhameed AS; Alam P; Khan RH
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Apr; 159():199-208. PubMed ID: 26851488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New palbociclib analogues modified at the terminal piperazine ring and their anticancer activities.
    Wang P; Huang J; Wang K; Gu Y
    Eur J Med Chem; 2016 Oct; 122():546-556. PubMed ID: 27448913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.